Table 1.

Patient demographics of AMR patients treated with bortezomib and belatacept

Patient	Age (yrs)	Gender	Donor Type	No. Previous KTx	Cause of ESRD	Induction	Immunosuppression before B/B
1	39	Male	Deceased	2	IgA Nephropathy	Basiliximab	Everolimus, Prednisolone, Mycophenolic acid
2	55	Female	Living	2	Reflux Nephropathy	ATG	Everolimus, CSA, Mycophenolic acid
3	64	Female	Deceased	0	Membranous Nephropathy	ATG	Everolimus, Mycophenolic acid
4	26	Male	Living	0	FSGS	ATG	Everolimus, CSA Mycophenolic acid
5	60	Female	Living	0	Contrast Induced Nephropathy	ATG	Everolimus, Mycophenolic acid
6	35	Male	Living	0	IgA Nephropathy	ATG	Everolimus, Mycophenolic acid